Elutia (ELUT) FCF Margin Growth (3y) (2022 - 2026)

Elutia (ELUT) FCF Margin Growth (3y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 38.00
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 30.00
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 943.00
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 96.00
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -2,196.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -20.00
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 2,679.00
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -461.00
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 417.00
10 Elutia 45.15 Mn 16.66 Mn 1.80 Mn -18,155.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -18,155.00
Dec 31, 2025 -70,263.00
Sep 30, 2025 -994.00
Jun 30, 2025 -4,637.00
Mar 31, 2025 -24,613.00
Dec 31, 2024 -37,956.00
Sep 30, 2024 -8,070.00
Jun 30, 2024 -6,140.00
Mar 31, 2024 150.00
Dec 31, 2023 -11,091.00
Sep 30, 2023 -7,048.00
Jun 30, 2023 788.00
Mar 31, 2023 -5,224.00
Dec 31, 2022 -5,903.00